Abstract Submission
The qualify for a presentation, the following deadlines and submission criteria must be respected.
Presentation of your abstract:
The reviewers will make a selection of the submitted abstracts that qualify for the oral presentations. The 3 selected authors will be asked to present their abstract (oral presentation of 15 min. incl 2 Q&A - on stage using PPT slides) during the Neuro Network Day 2020 from 10:45 until 11:40.
Submission Criteria:
Abstracts should be uploaded via the abstract submission system, which is accessible via the Symposium Website.
- All abstracts must be submitted electronically in .doc/docx format and should be written in English
- At the time of submission, the material should not have been published or accepted for publication. Encore abstracts are accepted but not favoured.
- The title of the abstract should include all the words crucial for a subject index
- The body of the abstract should be limited to maximum 300 words
- The subject should treat the results of a Clinical Case in Neurology
- In addition, there should be a title submitted with a maximum of 45 characters
- All abstracts have to be submitted by the main author
- If the abstract has more than one author, the main author should be clearly identified (fe: label: 'main author:')
Please note:
General Framework for Abstract Submission
- The submission of abstracts is welcome and highly appreciated
- Abstracts should be submitted via the available link on the Symposium website
- All submitted abstracts that fullfil the submission criteria, will be screened and considered for presentation by reviewers, appointed by the Scientific Committee, who will send a notification regarding acceptance or rejection of abstracts to the submitting author via email
- There is no cost linked to abstract submission
- Late breaking abstracts will not be accepted
- Abstracts with commercial content will not be accepted
Deadlines:
- Abstract Submission Deadline is Thursday, January 16, 2020
- Abstract Submission Feedback regarding acceptance/non-acceptance by Friday, January 24, 2020
Educational event sponsored by TEVA Pharma Belgium.
Zinc-number: BE/AJO/19/0036b/TevaPharmaBelgium/11.2019